ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 194 filers reported holding ARRAY BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $303,000 | +89.4% | 6,550 | 0.0% | 0.00% | +100.0% |
| Q1 2019 | $160,000 | +72.0% | 6,550 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $93,000 | -7.0% | 6,550 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $100,000 | -9.1% | 6,550 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $110,000 | +12.2% | 6,550 | +9.2% | 0.00% | 0.0% |
| Q1 2018 | $98,000 | +27.3% | 6,000 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $77,000 | +4.1% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $74,000 | +64.4% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $45,000 | -16.7% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $54,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|